Fresenius/€FRE
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Fresenius
Fresenius SE & Co. KGaA, operating under the ticker FRE, is a global healthcare group founded in 1912. The company specializes in products and services for dialysis, hospitals, and outpatient medical care. Operating in the healthcare sector, Fresenius provides a range of services including engineering and services for hospitals and other healthcare facilities.
Ticker
€FRE
Sector
Primary listing
XETRA
Industry
Health Care Providers & Services
Headquarters
Employees
175,202
ISIN
DE0005785604
Website
Fresenius Metrics
BasicAdvanced
€23B
55.45
€0.75
0.94
€1.00
2.40%
Price and volume
Market cap
€23B
Beta
0.94
52-week high
€44.40
52-week low
€27.81
Average daily volume
890K
Dividend rate
€1.00
Financial strength
Current ratio
1.429
Quick ratio
0.759
Long term debt to equity
56.776
Total debt to equity
67.912
Dividend payout ratio (TTM)
22.75%
Interest coverage (TTM)
3.62%
Profitability
EBITDA (TTM)
2,668
Gross margin (TTM)
24.28%
Net profit margin (TTM)
1.91%
Operating margin (TTM)
8.46%
Effective tax rate (TTM)
34.07%
Revenue per employee (TTM)
€130,000
Management effectiveness
Return on assets (TTM)
2.68%
Return on equity (TTM)
5.06%
Valuation
Price to earnings (TTM)
55.448
Price to revenue (TTM)
1.059
Price to book
1.21
Price to tangible book (TTM)
10.86
Price to free cash flow (TTM)
14.743
Free cash flow yield (TTM)
6.78%
Free cash flow per share (TTM)
282.30%
Dividend yield (TTM)
2.40%
Forward dividend yield
2.40%
Growth
Revenue change (TTM)
4.61%
Earnings per share change (TTM)
-162.90%
3-year revenue growth (CAGR)
-16.67%
10-year revenue growth (CAGR)
-1.01%
3-year earnings per share growth (CAGR)
-38.44%
10-year earnings per share growth (CAGR)
-9.70%
3-year dividend per share growth (CAGR)
2.82%
10-year dividend per share growth (CAGR)
8.56%
What the Analysts think about Fresenius
Analyst ratings (Buy, Hold, Sell) for Fresenius stock.
Bulls say / Bears say
Fresenius reported a 13% increase in fourth-quarter operating earnings, surpassing expectations, and achieved significant cost savings for 2023, leading to a share price rise of over 4%. (reuters.com)
The company exceeded second-quarter profit expectations due to strong performances by its Kabi and Helios units and successful cost-saving measures, with earnings before interest and taxes rising to €660 million, a 16% increase from the previous year. (reuters.com)
Fresenius raised its 2025 structural savings target to €400 million from €350 million, indicating a strong commitment to cost efficiency and profitability. (reuters.com)
Investors are seeking more transparency from Fresenius regarding its strategy and timeline for reducing control over its dialysis division, Fresenius Medical Care, which continues to deter potential shareholders. (reuters.com)
Fresenius Medical Care's shares fell as much as 9% after reporting second-quarter revenue that missed estimates due to underwhelming U.S. patient-care volume growth. (bloomberg.com)
Despite strong quarterly results, Fresenius Medical Care's shares fell 5% due to concerns over weak patient volume projections, with the company targeting slower growth compared to competitors. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.
Fresenius Financial Performance
Revenues and expenses
Fresenius Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fresenius stock?
Fresenius (FRE) has a market cap of €23B as of June 20, 2025.
What is the P/E ratio for Fresenius stock?
The price to earnings (P/E) ratio for Fresenius (FRE) stock is 55.45 as of June 20, 2025.
Does Fresenius stock pay dividends?
Yes, the Fresenius (FRE) stock pays dividends to shareholders. As of June 20, 2025, the dividend rate is €1 and the yield is 2.4%. Fresenius has a payout ratio of 22.75% on a trailing twelve-month basis.
When is the next Fresenius dividend payment date?
The next Fresenius (FRE) dividend payment date is unconfirmed.
What is the beta indicator for Fresenius?
Fresenius (FRE) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.